Soleno Therapeutics Inc. (SLNO)

New Form 8-K - SOLENO THERAPEUTICS INC Filed: 2025-08-18 AccNo: 0001193125-25-182184 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

180 Life Sciences Corp. (ATNF)

New Form 8-K/A - ETHZilla Corp Filed: 2025-08-18 AccNo: 0001213900-25-077692 Size: 322 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: …

Matinas Biopharma Holdings Inc. (MTNB)

New Form 8-K - Matinas BioPharma Holdings, Inc. Filed: 2025-08-18 AccNo: 0001641172-25-024520 Size: 284 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

Elevai Labs (ELAB)

New Form 8-K - PMGC Holdings Inc. Filed: 2025-08-18 AccNo: 0001213900-25-077686 Size: 263 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits